Business Description
Revvity Inc
NAICS : 334516
SIC : 8071
ISIN : US7140461093
Total Employee Number:
11,000Compare
Compare
Traded in other countries / regions
RVTY.USAPKN.GermanyPKI.Mexico0KHE.UKR1VT34.Brazil Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
1972-06-01Description
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | 4.52 | |||||
Interest Coverage | 5.44 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.77 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.2 | |||||
3-Year EBITDA Growth Rate | -11.1 | |||||
3-Year EPS without NRI Growth Rate | -9.9 | |||||
3-Year FCF Growth Rate | -2.4 | |||||
3-Year Book Growth Rate | 3.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 8.83 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.04 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.04 | |||||
9-Day RSI | 60.36 | |||||
14-Day RSI | 59.45 | |||||
3-1 Month Momentum % | 15.39 | |||||
6-1 Month Momentum % | 15.81 | |||||
12-1 Month Momentum % | 24.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.5 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 106.57 | |||||
Days Sales Outstanding | 87.41 | |||||
Days Payable | 48.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.24 | |||||
Dividend Payout Ratio | 0.05 | |||||
Forward Dividend Yield % | 0.24 | |||||
5-Year Yield-on-Cost % | 0.24 | |||||
3-Year Average Share Buyback Ratio | 3.8 | |||||
Shareholder Yield % | 3.66 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 54.98 | |||||
Operating Margin % | 12.27 | |||||
Net Margin % | 8.16 | |||||
EBITDA Margin % | 25.37 | |||||
FCF Margin % | 19.17 | |||||
OCF Margin % | 21.55 | |||||
ROE % | 3.25 | |||||
ROA % | 1.96 | |||||
ROIC % | 3.08 | |||||
3-Year ROIIC % | 11.35 | |||||
ROC (Joel Greenblatt) % | 26.53 | |||||
ROCE % | 2.97 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 55.64 | |||||
Forward PE Ratio | 21.82 | |||||
PE Ratio without NRI | 21.84 | |||||
Shiller PE Ratio | 25.66 | |||||
Price-to-Owner-Earnings | 26.33 | |||||
PS Ratio | 4.53 | |||||
PB Ratio | 1.8 | |||||
Price-to-Free-Cash-Flow | 23.64 | |||||
Price-to-Operating-Cash-Flow | 21.03 | |||||
EV-to-EBIT | 47.03 | |||||
EV-to-Forward-EBIT | 29.88 | |||||
EV-to-EBITDA | 20.79 | |||||
EV-to-Forward-EBITDA | 17.29 | |||||
EV-to-Revenue | 5.27 | |||||
EV-to-Forward-Revenue | 5.3 | |||||
EV-to-FCF | 27.51 | |||||
Price-to-GF-Value | 0.99 | |||||
Price-to-Projected-FCF | 1.09 | |||||
Price-to-Median-PS-Value | 1.1 | |||||
Earnings Yield (Greenblatt) % | 2.13 | |||||
FCF Yield % | 4.28 | |||||
Forward Rate of Return (Yacktman) % | -12.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:RVTY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Revvity Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,911.811 | ||
| EPS (TTM) ($) | 2.1 | ||
| Beta | 1.1729 | ||
| 3-Year Sharpe Ratio | -0.04 | ||
| 3-Year Sortino Ratio | -0.06 | ||
| Volatility % | 33.25 | ||
| 14-Day RSI | 59.45 | ||
| 14-Day ATR ($) | 3.624948 | ||
| 20-Day SMA ($) | 113.2325 | ||
| 12-1 Month Momentum % | 24.33 | ||
| 52-Week Range ($) | 81.22 - 118.34 | ||
| Shares Outstanding (Mil) | 111.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Revvity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Revvity Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-02 08:00 | In 171 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-02 | In 170 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-27 08:00 | In 73 days | ||
| Third quarter earnings results for 2026 | 2026-10-27 | In 72 days | ||
| USD 0.070000 Cash Dividend | 2026-10-23 | In 68 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 07:30 | 115.22 (+2.44%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 115.22 (+2.44%) | ||
| USD 0.070000 Cash Dividend | 2026-07-17 | 111.70 (+0.89%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 08:40 | 100.30 (+0.19%) | ||
| Guidance call for 2026 | 2026-05-13 09:20 | 99.30 (+0.04%) |
Show
Entries
Revvity Inc Frequently Asked Questions
What is Revvity Inc(RVTY)'s stock price today?
The current price of RVTY is $116.84. The 52 week high of RVTY is $118.34 and 52 week low is $81.22.
When is next earnings date of Revvity Inc(RVTY)?
The next earnings date of Revvity Inc(RVTY) is 2026-10-27 Est..
Does Revvity Inc(RVTY) pay dividends? If so, how much?
The Dividend Yield %  of Revvity Inc(RVTY) is 0.24% (As of Today), Highest Dividend Payout Ratio of Revvity Inc(RVTY) was 0.19. The lowest was 0.03. And the median was 0.06. The  Forward Dividend Yield % of Revvity Inc(RVTY) is 0.24%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:RVTY
No articles.
Press Release
Articles on Revvity Inc
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing
4 days ago
Headlines
See More- 1
Aug 11, 2026
Stock futures edge lower as traders focus on Strait of Hormuz reopening
Seeking Alpha • 3:04am
Aug 04, 2026
Revvity beats top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha • 5:12am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers